ABSCI CORP reports a Return on Equity (ROE) of -68.87%.

What is ABSI's dividend yield?

ABSCI CORP offers a dividend yield of 0.00%.

What is ABSI's Deepscope Quality Score?

Deepscope rates ABSI's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ABSI?

Deepscope's AI Timing Score for ABSI is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ABSI belong to?

ABSCI CORP is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Cổ phiếu ABSI (NASDAQ) | ABSCI CORP

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-10 | FS: 2026-03-31)

ABSI

ABSCI CORP

US:NASDAQ STOCK Healthcare >> Biotechnology News 97

USD 6.38

-0.45 (-6.59%) Day Change

Watchlist Portfolio Compare Chart

0.01

D/E

-68.9%

ROE

-60.6%

ROA

0.00%

Div Yield

ABSCI CORP
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 6.38 Price -0.45 (-6.59%) Day Change	NEWS SCORE: 97

ABSI Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 23) nhưng Thời điểm mua ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.09 From 30 days period
News Score	97
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	6.38
PBV / Sector	6.19 / 4.79
Earning Per Share	-0.71

PE / Sector	N/A / 17.89
PEG or PE/Growth / Sector	N/A / 0.56
Average 1M Daily Value	27.80 M GREAT
Average 1W Daily Value	36.90 M GREAT

Yếu tố Kỹ thuật

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-6,450.76 / 468.85
NPM Average (%) / Sector	-3,319.50 / -1,531.69
NPM Change Average (%) / Sector	40.31 / 5,028.65 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-60.55 / 31.69
ROA Average (%) / Sector	-49.13 / -353.18
ROA Change Average (%) / Sector	18.65 / 5,214.65 GOOD
ROE (%) / Sector	-68.87 / 10.58
ROE Average (%) / Sector	-57.64 / 27.64
ROE Change Average (%) / Sector	18.70 / 2,048.88 GOOD
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.77

Chi tiết đăng ký

Analyze Date	2026-06-11 09:54:38
Symbol	ABSI
Name	ABSCI CORP
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	155.91 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,064.83 / 8,963.32

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 18105 SE Mill Plain Boulevard, Vancouver, WA, United States, 98683

Phone: 360 949 1041

Website: https://www.absci.com

Employees: 140

Sector: Healthcare >> Biotechnology

Description: Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.